News

AECC funds Bionanomechanics lab to advance nanotechnology based early cancer detection

Coinciding with World Day against Lung Cancer, the Spanish Association Against Cancer (AECC) cites in its press release the project, coordinated by Javier Tamayo and co-led by Priscila Kosaka, whose objective is the early detection of Lung cancer through a blood test with a much more sensitive technique than that currently used for the detection of tumor markers. This nanotechnology-based technique, applied to the at-risk population, could increase survival in this type of tumor since it would enable diagnosis at a stage where treatments are much more effective.

Newspapers and TV have echoed the news.

http://www.rtve.es/noticias/20151117/analisis-sanguineo-basado-nanotecnologia-podria-detectar-precozmente-cancer-pulmon/1255921.shtml

http://www.lasexta.com/constantes-vitales/noticias/proyecto-financiado-aecc-detectara-precozmente-cancer-pulmon_2015111700092.html

http://politica.elpais.com/politica/2015/11/17/actualidad/1447755460_501589.html


Source: https://www.aecc.es/Comunicacion/Noticias/Paginas/UnproyectofinanciadoAECCdetectarcancerpulmonnanotecnologia.aspx

Latest Posts

  • Mecwins announces licensing and co-development agreement with Quidel

    Mecwins Announces Strategic Partnership to Develop a Next Generation Platform for Point of Care (POC) Testing This licensing and co-development agreement leverages Mecwins’ ultrasensitive AVAC platform and Quidel’s extensive expertise in POC assay and cartridge development. Ultrasensitive POC testing will facilitate developing new tests, incorporating biomarkers and indications not possible with current technologies. Quidel got…

Micro and Nanotechnology Institute
PTM – C/Isaac Newton, 8
28760 – Tres Cantos – MADRID
Tfn. (+ 34) 91 806 07 00
Fax. (+ 34) 91 806 07 01

Follow us